Document Detail


The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.
MedLine Citation:
PMID:  19651826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of bisphosphonates in the treatment of avascular necrosis of the femoral head is an encouraging but relatively new option with most published data being derived from small trials with limited follow-up. We present a clinicoradiological analysis of 395 hips with avascular necrosis which were treated with oral alendronate for three years with a mean follow-up of four years (1 to 8). Our results show an improvement in the clinical function, a reduction in the rate of collapse and a decrease in the requirement for total hip replacement, compared with the findings of other studies in which no treatment was given. This improvement is particularly marked if the treatment is begun in the pre-collapse stages of the disease. Even in Ficat stage-III hips some benefit was obtained from treatment with alendronate by at least a delay in the need for total hip replacement.
Authors:
S Agarwala; S Shah; V R Joshi
Related Documents :
11847626 - Psoas abscess associated with infected total hip arthroplasty.
9206076 - Vascularized iliac periosteal transfer for the treatment of avascular necrosis of the f...
14673446 - Hip arthroscopy in the presence of dysplasia.
16766936 - Life expectancy and functional prognosis after femoral neck fractures in hemodialysis p...
21680076 - After dentoalveolar surgery, most patients are satisfied with telephone follow-up.
6839586 - Acute tears of the rotator cuff. the timing of surgical repair.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of bone and joint surgery. British volume     Volume:  91     ISSN:  0301-620X     ISO Abbreviation:  J Bone Joint Surg Br     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-04     Completed Date:  2009-08-31     Revised Date:  2010-11-10    
Medline Journal Info:
Nlm Unique ID:  0375355     Medline TA:  J Bone Joint Surg Br     Country:  England    
Other Details:
Languages:  eng     Pagination:  1013-8     Citation Subset:  AIM; IM    
Affiliation:
P. D. Hinduja National Hospital and Medical Research Centre, Mahim, Mumbai 400016, India. drsa@rediff.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Alendronate / therapeutic use*
Bone Density Conservation Agents / therapeutic use*
Female
Femoral Fractures / prevention & control*
Femur Head Necrosis / drug therapy*
Follow-Up Studies
Humans
Male
Middle Aged
Pain Measurement
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Bone Density Conservation Agents; 66376-36-1/Alendronate
Comments/Corrections
Comment In:
Z Orthop Unfall. 2009 Nov-Dec;147(6):657   [PMID:  20017096 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autologous capping during resection arthroplasty of the hip in patients with cerebral palsy.
Next Document:  Hip resurfacings revised for inflammatory pseudotumour have a poor outcome.